{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:18:29Z","timestamp":1793121509223,"version":"4.5.0"},"reference-count":78,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2019,10,1]]},"DOI":"10.1001\/jamaoncol.2019.0620","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T11:02:36Z","timestamp":1558004556000},"page":"1489","source":"Crossref","is-referenced-by-count":152,"title":["Insights Into Breast Cancer in the East vs the West"],"prefix":"10.1001","volume":"5","author":[{"given":"Yoon-Sim","family":"Yap","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, National Cancer Centre Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Shen","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eon","family":"Lee","sequence":"additional","affiliation":[{"name":"Breast Division, Department of Surgery, Samsung Medical Center, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Radiology, Samsung Medical Center, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Hee","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-Yong","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hung","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Toi","sequence":"additional","affiliation":[{"name":"Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Chin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore"},{"name":"Cancer Science Institute, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"crv190002r1","doi-asserted-by":"publisher","first-page":"e3862","DOI":"10.1371\/journal.pone.0003862","article-title":"Analysis of East Asia genetic substructure using genome-wide SNP arrays.","volume":"3","author":"Tian","year":"2008","journal-title":"PLoS One"},{"issue":"6","key":"crv190002r2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.v68.6","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"crv190002r4","doi-asserted-by":"publisher","first-page":"djv107","DOI":"10.1093\/jnci\/djv107","article-title":"Female breast cancer incidence among Asian and Western populations: more similar than expected.","volume":"107","author":"Sung","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"crv190002r5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/ijc.v139.3","article-title":"The impact of breast cancer\u2013specific birth cohort effects among younger and older Chinese populations.","volume":"139","author":"Sung","year":"2016","journal-title":"Int J Cancer"},{"issue":"2","key":"crv190002r6","first-page":"101","article-title":"Incidence and mortality of female breast cancer in the Asia-Pacific region.","volume":"11","author":"Youlden","year":"2014","journal-title":"Cancer Biol Med"},{"issue":"11","key":"crv190002r7","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1002\/ijc.v130.11","article-title":"The emerging epidemic of estrogen-related cancers in young women in a developing Asian country.","volume":"130","author":"Lin","year":"2012","journal-title":"Int J Cancer"},{"issue":"7","key":"crv190002r8","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S1470-2045(13)70567-9","article-title":"Breast cancer in China.","volume":"15","author":"Fan","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9","key":"crv190002r9","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1634\/theoncologist.2014-0290","article-title":"Breast cancer disparities: a multicenter comparison of tumor diagnosis, characteristics, and surgical treatment in China and the US.","volume":"20","author":"Sivasubramaniam","year":"2015","journal-title":"Oncologist"},{"issue":"3","key":"crv190002r10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12282-015-0599-6","article-title":"Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011.","volume":"22","author":"Kurebayashi","year":"2015","journal-title":"Breast Cancer"},{"issue":"1","key":"crv190002r11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4048\/jbc.2018.21.1.1","article-title":"Basic findings regarding breast cancer in Korea in 2015: data from a breast cancer registry.","volume":"21","author":"Kang","year":"2018","journal-title":"J Breast Cancer"},{"key":"crv190002r12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.breast.2016.01.004","article-title":"Characteristics of breast cancer in Central China, literature review and comparison with USA.","volume":"30","author":"Chen","year":"2016","journal-title":"Breast"},{"issue":"1","key":"crv190002r13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4048\/jbc.2015.18.1.8","article-title":"Survival improvement in Korean breast cancer patients due to increases in early-stage cancers and hormone receptor positive\/HER2 negative subtypes: a nationwide registry-based study.","volume":"18","author":"You","year":"2015","journal-title":"J Breast Cancer"},{"issue":"1","key":"crv190002r14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10549-018-4947-z","article-title":"Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?","volume":"173","author":"Lee","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"crv190002r15","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","article-title":"Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries.","volume":"6","author":"Zeng","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"6","key":"crv190002r16","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1158\/1055-9965.EPI-09-0096","article-title":"Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia.","volume":"18","author":"Lin","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"crv190002r17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1634\/theoncologist.2014-0047","article-title":"Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study.","volume":"19","author":"Lin","year":"2014","journal-title":"Oncologist"},{"issue":"7","key":"crv190002r18","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.envint.2007.04.008","article-title":"Daily intake of 4-nonylphenol in Taiwanese.","volume":"33","author":"Lu","year":"2007","journal-title":"Environ Int"},{"issue":"2","key":"crv190002r19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10549-010-1173-8","article-title":"Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry.","volume":"127","author":"Telli","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"crv190002r20","first-page":"337","article-title":"Distinct breast cancer subtypes in women with early-onset disease across races.","volume":"4","author":"Singh","year":"2014","journal-title":"Am J Cancer Res"},{"issue":"7","key":"crv190002r21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/cam4.2015.4.issue-7","article-title":"Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype.","volume":"4","author":"Huang","year":"2015","journal-title":"Cancer Med"},{"issue":"5","key":"crv190002r22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1158\/1055-9965.EPI-13-1023","article-title":"Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.","volume":"23","author":"Sweeney","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"crv190002r23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41523-018-0070-x","article-title":"Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers.","volume":"4","author":"Yap","year":"2018","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"crv190002r24","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41467-018-04129-4","article-title":"Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.","volume":"9","author":"Kan","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"crv190002r25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2014.17322","article-title":"Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.","volume":"313","author":"Iqbal","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"crv190002r26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ng.2955","article-title":"Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.","volume":"46","author":"Nik-Zainal","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"crv190002r27","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1371\/journal.pgen.0030063","article-title":"Population stratification of a common APOBEC gene deletion polymorphism.","volume":"3","author":"Kidd","year":"2007","journal-title":"PLoS Genet"},{"issue":"1","key":"crv190002r28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13058-016-0717-1","article-title":"Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.","volume":"18","author":"Wen","year":"2016","journal-title":"Breast Cancer Res"},{"issue":"1","key":"crv190002r29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ijc.v141.1","article-title":"The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: screening of 2,991 patients and 1,043 controls by next-generation sequencing.","volume":"141","author":"Lang","year":"2017","journal-title":"Int J Cancer"},{"issue":"1","key":"crv190002r30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/GCO.0b013e328332dca3","article-title":"BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications.","volume":"22","author":"Kurian","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"20","key":"crv190002r31","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1158\/1078-0432.CCR-16-3227","article-title":"Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients.","volume":"23","author":"Sun","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"crv190002r32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/jmedgenet-2015-103132","article-title":"Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries.","volume":"53","author":"Kwong","year":"2016","journal-title":"J Med Genet"},{"issue":"1","key":"crv190002r33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10549-015-3377-4","article-title":"The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study.","volume":"151","author":"Kang","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"crv190002r34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/tbj.2018.24.issue-1","article-title":"Unexpectedly low frequency of BRCA1\/2 deleterious mutations in Japanese patients with breast cancer.","volume":"24","author":"Sakamoto","year":"2018","journal-title":"Breast J"},{"issue":"5","key":"crv190002r35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/humu.2018.39.issue-5","article-title":"Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.","volume":"39","author":"Rebbeck","year":"2018","journal-title":"Hum Mutat"},{"issue":"2","key":"crv190002r36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/gim.2017.96","article-title":"Racial\/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.","volume":"20","author":"Caswell-Jin","year":"2018","journal-title":"Genet Med"},{"issue":"2","key":"crv190002r37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ijc.v144.2","article-title":"Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.","volume":"144","author":"Li","year":"2019","journal-title":"Int J Cancer"},{"issue":"1","key":"crv190002r38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12885-017-3940-y","article-title":"Variants of cancer susceptibility genes in Korean BRCA1\/2 mutation-negative patients with high risk for hereditary breast cancer.","volume":"18","author":"Park","year":"2018","journal-title":"BMC Cancer"},{"key":"crv190002r39","doi-asserted-by":"publisher","first-page":"15003","DOI":"10.1038\/npjgenmed.2015.3","article-title":"Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore.","volume":"1","author":"Wong","year":"2016","journal-title":"NPJ Genom Med"},{"issue":"13","key":"crv190002r40","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer.","volume":"34","author":"Tung","year":"2016","journal-title":"J Clin Oncol"},{"issue":"14","key":"crv190002r41","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1200\/JCO.2008.16.4335","article-title":"CHEK2*1100delC screening of Asian women with a family history of breast cancer is unwarranted.","volume":"26","author":"Lee","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"crv190002r42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1158\/1055-9965.EPI-17-0169","article-title":"Genome-wide association studies of cancer in diverse populations.","volume":"27","author":"Park","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"crv190002r43","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/hmg\/ddt089","article-title":"Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls.","volume":"22","author":"Zheng","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"7678","key":"crv190002r44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","article-title":"Association analysis identifies 65 new breast cancer risk loci.","volume":"551","author":"Michailidou","year":"2017","journal-title":"Nature"},{"issue":"3","key":"crv190002r45","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/bcr3678","article-title":"Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population.","volume":"16","author":"Lee","year":"2014","journal-title":"Breast Cancer Res"},{"issue":"2","key":"crv190002r46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1517\/14622416.3.2.229","article-title":"CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.","volume":"3","author":"Bradford","year":"2002","journal-title":"Pharmacogenomics"},{"issue":"24","key":"crv190002r47","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1200\/JCO.2010.31.4427","article-title":"Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study.","volume":"29","author":"Irvin","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"crv190002r48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10549-011-1777-7","article-title":"Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients.","volume":"131","author":"Kiyotani","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"crv190002r49","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1210\/jc.2005-1643","article-title":"Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism.","volume":"91","author":"Jakobsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"crv190002r50","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1200\/JCO.2017.35.15_suppl.1056","article-title":"Prospective study of UDP-glucuronosyltransferase (UGT) 2B17 genotype and exemestane (Exe) pharmacokinetics (PK) and pharmacodynamics (PD) in Asian, hormone receptor (HR) positive, metastatic breast cancer (MBC) patients.","volume":"35","author":"Walsh","year":"2017","journal-title":"J Clin Oncol"},{"issue":"13","key":"crv190002r51","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1200\/JCO.2007.15.2090","article-title":"Potential regional differences for the tolerability profiles of fluoropyrimidines.","volume":"26","author":"Haller","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"crv190002r52","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/tpj.2012.26","article-title":"Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?","volume":"13","author":"Loh","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"crv190002r53","doi-asserted-by":"publisher","first-page":"27826","DOI":"10.1038\/srep27826","article-title":"Pharmacogenetics: guided phase I study of capecitabine on an intermittent schedule in patients with advanced or metastatic solid tumours.","volume":"6","author":"Soo","year":"2016","journal-title":"Sci Rep"},{"issue":"11","key":"crv190002r54","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1001\/jamaoncol.2017.1269","article-title":"Predictors of hand-foot syndrome and pyridoxine for prevention of capecitabine-induced hand-foot syndrome: a randomized clinical trial.","volume":"3","author":"Yap","year":"2017","journal-title":"JAMA Oncol"},{"issue":"5","key":"crv190002r55","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/cas.2015.106.issue-5","article-title":"Pharmacokinetics, dynamics and toxicity of docetaxel: why the Japanese dose differs from the Western dose.","volume":"106","author":"Kenmotsu","year":"2015","journal-title":"Cancer Sci"},{"issue":"17","key":"crv190002r56","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1200\/JCO.2002.01.025","article-title":"Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies.","volume":"20","author":"Goh","year":"2002","journal-title":"J Clin Oncol"},{"issue":"7","key":"crv190002r57","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1634\/theoncologist.2014-0033","article-title":"Safety profile of pertuzumab with trastuzumab and docetaxel in patients from Asia with human epidermal growth factor receptor 2\u2013positive metastatic breast cancer: results from the phase III trial CLEOPATRA.","volume":"19","author":"Swain","year":"2014","journal-title":"Oncologist"},{"issue":"3","key":"crv190002r58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00280-016-3099-2","article-title":"Ethnic sensitivity assessment of the antibody-drug conjugate trastuzumab emtansine (T-DM1) in patients with HER2-positive locally advanced or metastatic breast cancer.","volume":"78","author":"Li","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"crv190002r59","article-title":"Abstract P1-13-11: neratinib in the extended adjuvant treatment of patients from Asia with early-stage HER2+ breast cancer after trastuzumab-based therapy: exploratory analyses from the phase III ExteNET trial.","volume":"78","author":"Iwata","year":"2018","journal-title":"Cancer Res"},{"issue":"6","key":"crv190002r60","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s12282-013-0444-8","article-title":"Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor\u2013positive breast cancer in BOLERO-2.","volume":"21","author":"Noguchi","year":"2014","journal-title":"Breast Cancer"},{"issue":"1","key":"crv190002r61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13058-017-0839-0","article-title":"Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1.","volume":"19","author":"Toi","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"4","key":"crv190002r62","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JGO.2016.008318","article-title":"PALOMA-3: phase III trial of fulvestrant with or without palbociclib in premenopausal and postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer that progressed on prior endocrine therapy-safety and efficacy in Asian patients.","volume":"3","author":"Iwata","year":"2017","journal-title":"J Glob Oncol"},{"issue":"27","key":"crv190002r63","article-title":"LBA1 first-line ribociclib + letrozole in postmenopausal Asian women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2\u2013) advanced breast cancer (ABC): a subgroup analysis from MONALEESA-2.","author":"Yap","year":"2016","journal-title":"Ann Oncol"},{"issue":"12","key":"crv190002r64","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/s41416-018-0102-1","article-title":"Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials.","volume":"118","author":"Yokota","year":"2018","journal-title":"Br J Cancer"},{"issue":"4","key":"crv190002r65","first-page":"332","article-title":"Mammographic density and breast cancer in three ethnic groups.","volume":"12","author":"Ursin","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"crv190002r66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10549-006-9387-5","article-title":"Ethnic and geographic differences in mammographic density and their association with breast cancer incidence.","volume":"104","author":"Maskarinec","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"crv190002r67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41523-018-0055-9","article-title":"Breast cancer risk factors and mammographic density among high-risk women in urban China.","volume":"4","author":"Sung","year":"2018","journal-title":"NPJ Breast Cancer"},{"issue":"4","key":"crv190002r68","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2214\/AJR.06.0619","article-title":"Mammographic breast density and race.","volume":"188","author":"del Carmen","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"crv190002r69","doi-asserted-by":"publisher","first-page":"e70217","DOI":"10.1371\/journal.pone.0070217","article-title":"Age and ethnic differences in volumetric breast density in New Zealand women: a cross-sectional study.","volume":"8","author":"Ellison-Loschmann","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"crv190002r70","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1158\/1055-9965.EPI-05-0798","article-title":"A longitudinal investigation of mammographic density: the Multiethnic Cohort.","volume":"15","author":"Maskarinec","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10016","key":"crv190002r71","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(15)00774-6","article-title":"Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.","volume":"387","author":"Ohuchi","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"crv190002r72","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/bjc.2015.33","article-title":"A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women.","volume":"112","author":"Shen","year":"2015","journal-title":"Br J Cancer"},{"issue":"11","key":"crv190002r73","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/jamaoncol.2017.1256","article-title":"Breast cancer screening with mammography plus ultrasonography or magnetic resonance imaging in women 50 years or younger at diagnosis and treated with breast conservation therapy.","volume":"3","author":"Cho","year":"2017","journal-title":"JAMA Oncol"},{"key":"crv190002r74","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.breast.2018.04.013","article-title":"Validation of the AJCC 8th prognostic system for breast cancer in an Asian healthcare setting.","volume":"40","author":"Wong","year":"2018","journal-title":"Breast"},{"issue":"1","key":"crv190002r75","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijrobp.2008.07.066","article-title":"Trends and patterns of breast conservation treatment in Hong Kong: 1994-2007.","volume":"74","author":"Yau","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"crv190002r76","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5999\/aps.2017.00836","article-title":"Selection of oncoplastic surgical technique in Asian breast cancer patients.","volume":"45","author":"Shin","year":"2018","journal-title":"Arch Plast Surg"},{"issue":"5","key":"crv190002r77","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5999\/aps.2012.39.5.489","article-title":"Usefulness of oncoplastic volume replacement techniques after breast conserving surgery in small to moderate-sized breasts.","volume":"39","author":"Yang","year":"2012","journal-title":"Arch Plast Surg"},{"issue":"1","key":"crv190002r78","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10549-017-4314-5","article-title":"First international consensus conference on standardization of oncoplastic breast conserving surgery.","volume":"165","author":"Weber","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"crv190002r3","volume-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay","year":"2018"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2733796\/jamaoncology_yap_2019_rv_190002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T18:38:13Z","timestamp":1570732693000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2733796"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":78,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.0620","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,1]]}}}